drugset / Trial / NCT00131443

Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine

NCT00131443

RandomizedParallel-groupDouble-blind

Summary

The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.

Timeline

Start
2004-02
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 25 mg
Subject Topiramate Small molecule 100 mg